Cargando…
Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function
BACKGROUND: Delocalization of neuronal nitric oxide synthase (nNOS) from the sarcolemma leads to functional muscle ischemia. This contributes to the pathogenesis in cachexia, aging and muscular dystrophy. Mutations in the gene encoding dystrophin result in Duchenne muscular dystrophy (DMD) and Becke...
Autores principales: | Zhao, Junling, Yang, Hsiao Tung, Wasala, Lakmini, Zhang, Keqing, Yue, Yongping, Duan, Dongsheng, Lai, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607532/ https://www.ncbi.nlm.nih.gov/pubmed/31266455 http://dx.doi.org/10.1186/s10020-019-0101-6 |
Ejemplares similares
-
Dystrophin R16/17-syntrophin PDZ fusion protein restores sarcolemmal nNOSμ
por: Patel, Aman, et al.
Publicado: (2018) -
A Hypothesis for Examining Skeletal Muscle Biopsy-Derived Sarcolemmal nNOSμ as Surrogate for Enteric nNOSα Function
por: Chaudhury, Arun
Publicado: (2015) -
Commentary: A Hypothesis for Examining Skeletal Muscle Biopsy-Derived Sarcolemmal nNOSμ as Surrogate for Enteric nNOSα Function
por: Percival, Justin
Publicado: (2015) -
In vivo requirement of the α-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4
por: Adams, Marvin E., et al.
Publicado: (2001) -
Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is Paralleled by Loss of Sarcolemmal nNOS
por: Meinen, Sarina, et al.
Publicado: (2012)